Cargando…
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer
Despite therapeutic gains in the treatment of HER2-positive (HER2: human epidermal growth factor receptor 2) advanced/metastatic breast cancer, there remains an urgent need for more effective treatment options. At present, there is no definitive approved standard therapy beyond second-line treatment...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216785/ https://www.ncbi.nlm.nih.gov/pubmed/34168380 http://dx.doi.org/10.1055/a-1471-4063 |